Schmidt, C J <br/><br/>
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.  [electronic resource] 

 -  European journal of pharmacology  Sep 1992 
 - 151-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0014-2999 
<br/><br/><label>Standard No.: </label>10.1016/0014-2999(92)90743-n  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Methylenedioxyamphetamine--pharmacology<br/>Animals<br/>Brain--drug effects<br/>Corpus Striatum--drug effects<br/>Dopamine--biosynthesis<br/>Electrophysiology<br/>Levodopa--pharmacology<br/>Male<br/>Methyltyrosines--pharmacology<br/>Neurons--drug effects<br/>Piperidines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Serotonin--drug effects<br/>Serotonin--metabolism<br/>Serotonin Antagonists--pharmacology<br/>alpha-Methyltyrosine